B细胞淋巴瘤6表达与正常反应体外受精人群活产无关
OBJECTIVE: To determine whether increased endometrial B-cell lymphoma 6 (BCL6) expression is associated with live birth in a normal responder in vitro fertilization (IVF) population. DESIGN: Case-control study. SETTING: University-affiliated infertility center.…
要点
- 以HSCORE>1.4为阳性,未活产组8/23阳性,活产组7/27阳性。
核心结论
- 在正常反应体外受精人群中,BCL6过表达与体外受精成功无关;实施BCL6检测用于临床决策的医生应告知患者,该结果在此人群中预测体外受精结局的效用可能有限。
研究设计与样本
- 病例对照研究,纳入两组接受体外受精并行胚胎植入前非整倍体检测后行冻融单整倍体胚胎移植的女性;第1组为未活产者,第2组为活产者。
主要发现
- 共纳入27例活产患者和23例未活产患者。
- 以HSCORE>1.4为阳性,未活产组23例中8例BCL6阳性,活产组27例中7例阳性。
关键数值与推荐
- BCL6过表达定义为免疫组化平均HSCORE以>1.4为阳性阈值,如文献先前所述。
临床怎么用
- 医生实施BCL6检测作为临床决策诊断工具时,应告知患者该结果在此正常反应人群中预测体外受精结局的效用可能有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether increased endometrial B-cell lymphoma 6 (BCL6) expression is associated with live birth in a normal responder in vitro fertilization (IVF) population. DESIGN: Case-control study. SETTING: University-affiliated infertility center. PATIENT(S): Two groups of women undergoing IVF with preimplantation genetic testing for aneuploidy followed by warmed, single, euploid embryo transfer. Group 1 consisted of women who failed to achieve live birth, and group 2 consisted of women who achieved live birth. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Endometrial BCL6 expression measured by immunohistochemistry in endometrial tissue samples. Overexpression was defined by mean HSCORE with a cutoff of positivity of >1.4, as previously described in the literature. RESULT(S): Twenty-seven patients who achieved live birth and 23 patients who failed to achieve live birth were included. B-cell lymphoma 6 expression/HSCORE and live birth rate were not associated (Odds ratio [OR], 0.78 [0.24-2.55]). Using a cutoff of >1.4 for positivity, 8 of 23 samples were positive for BCL6 in the no live birth group, whereas 7 of 27 were positive in the live birth group. There was no significant association between BCL6 positivity and live birth (OR, 0.66 [0.19-2.21]). CONCLUSION(S): The proportion of patients with BCL6 positivity did not significantly differ between those who achieved live birth and those who did not. In the population of patients at our center, who compromise of women who respond normally to IVF stimulation, BCL6 overexpression was not associated with IVF success. Physicians implementing BCL6 testing as a diagnostic tool for clinical decision making should counsel patients that results may have limited utility in predicting IVF outcomes in this population.
引用
- Klimczak AM, Herlihy NS, Scott CS, et al. B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population. Fertil Steril. 2021. PMID: 34809978. doi:10.1016/j.fertnstert.2021.09.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。